27 studies found for:
ATTRACT
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
|
||||
| 2 | Active, not recruiting |
CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
|
||||
| 3 | Terminated |
The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)
|
||||
| 4 | Recruiting |
Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System)
|
||||
| 5 | Terminated |
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
|
||||
| 6 | Active, not recruiting |
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
|
||||
| 7 | Completed |
A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine
|
||||
| 8 | Completed |
Intra-uterine Injection of Human Chorionic Gonadotrophin (hCG) Before Embryo Transfer
|
||||
| 9 | Completed |
A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)
|
||||
| 10 | Not yet recruiting |
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
|
||||
| 11 | Recruiting |
Phase 2A Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
|
||||
| 12 | Not yet recruiting |
Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients
|
||||
| 13 | Completed |
Prediction of Acute Rejection in Renal Transplant
|
||||
| 14 | Unknown † |
"Step by Step": A Feasibility Study of the Promotion of Lunchtime Walking to Increase Physical Activity and Improve Mental Well-being in Sedentary Employees
|
||||
| 15 | Unknown † |
Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
|
||||
| 16 | Completed |
NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
|
||||
| 17 | Active, not recruiting |
Queen's University Investigation of Calcification in Chronic Kidney Disease
|
||||
| 18 | Active, not recruiting |
Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland
|
||||
| 19 | Recruiting |
Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral ß-glucan for High-Risk Neuroblastoma
|
||||
| 20 | Completed |
Research in Skin Inflammation
|
† Indicates status has not been verified in more than two years
